Current and Potential Application of GnRH Agonists in Gynecologic Practice

JOHN M. TZAFETTAS
DOI: https://doi.org/10.1111/j.1749-6632.2000.tb06258.x
IF: 6.499
2006-01-25
Annals of the New York Academy of Sciences
Abstract:The development of GnRH-a (analogues or agonists) is a major leap forward in the treatment of various hormone-dependent diseases in medicine. Their introduction in reproductive endocrinology, in in vitro fertilization/embryo transfer (IVF/ET) and other assisted reproduction techniques had a revolutionary impact. They have been effective in other gynecologic conditions including fibroids, endometriosis, anovulatory disorders, precocious puberty, dysfunctional uterine bleeding, and operative hysteroscopy. Medical castration induced by GnRH-a has become first-line therapy in metastatic breast cancer. Their long-term use, though, has been associated with a variety of adverse effects such as bone loss and decreased cardioprotection. "Steroid add-back" therapy in these cases apparently is an effective alternative. It may allow their safe long-term application beyond 6 months, averting unpleasant side-effects and maintaining bone mass and cardioprotection.
multidisciplinary sciences
What problem does this paper attempt to address?